Protein interaction profiling of the p97 adaptor UBXD1 points to a role for the complex in modulating ERGIC-53 trafficking

Molecular and Cellular Proteomics

Volumn 11, Issue 6, 2012, Pages

  Haines, Dale S ^a   Lee, J Eugene ^b   Beauparlant, Stephen L ^a   Kyle, Dane B ^a   Den Besten, Willem ^b   Sweredoski, Michael J ^b   Graham, Robert L J ^b   Hess, Sonja ^b   Deshaies, Raymond J ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; MEMBRANE PROTEIN; MUTANT PROTEIN; PROTEIN ERGIC 53; PROTEIN P97; PROTEIN UBXD1; UNCLASSIFIED DRUG; 4(4 (5 NITRO FURAN 2 YLMETHYLENE) 3,5 DIOXO PYRAZOLIDIN 1 YL) BENZOIC ACID ETHYL ESTER; 4(4-(5-NITRO-FURAN-2-YLMETHYLENE)-3,5-DIOXO-PYRAZOLIDIN-1-YL)-BENZOIC ACID ETHYL ESTER; ADENOSINE TRIPHOSPHATASE; BENZOIC ACID DERIVATIVE; CARRIER PROTEIN; FURAN DERIVATIVE; LMAN1 PROTEIN, HUMAN; MANNOSE BINDING LECTIN; N2,N4 DIBENZYLQUINAZOLINE 2,4 DIAMINE; N2,N4-DIBENZYLQUINAZOLINE-2,4-DIAMINE; NUCLEAR PROTEIN; P97 ATPASE; PYRAZOLE DERIVATIVE; QUINAZOLINE DERIVATIVE; RAB PROTEIN; UBIQUITIN PROTEIN LIGASE; UBXD1 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MYOPATHY; PAGET BONE DISEASE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; PROTEOMICS; WESTERN BLOTTING; CHEMISTRY; DRUG ANTAGONISM; METABOLISM; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; SECRETORY VESICLE; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATASES; BENZOIC ACIDS; CARRIER PROTEINS; CELL LINE, TUMOR; FURANS; HUMANS; MANNOSE-BINDING LECTINS; MEMBRANE PROTEINS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN TRANSPORT; PYRAZOLES; QUINAZOLINES; RAB3 GTP-BINDING PROTEINS; SECRETORY VESICLES; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84862321639     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.016444     Document Type: Article

References (40)

1. Watts, G. D., Wymer, J., Kovach, M. J., Mehta, S. G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M. P., and Kimonis, V. E. (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377-381
2. Johnson, J. O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V. M., Trojanowski, J. Q., Gibbs, J. R., Brunetti, M., Gronka, S., Wuu, J., Ding, J., McCluskey, L., Martinez-Lage, M., Falcone, D., Hernandez, D. G., Arepalli, S., Chong, S., Schymick, J. C., Rothstein, J., Landi, F., Wang, Y. D., Calvo, A., Mora, G., Sabatelli, M., Monsurrò, M. R., Battistini, S., Salvi, F., Spataro, R., Sola, P., Borghero, G.; ITALSGEN Consortium, Galassi, G., Scholz, S. W., Taylor, J. P., Restagno, G., Chiò, A., and Traynor, B. J. (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68, 857-864
3. Uchiyama, K., and Kondo, H. (2005) p97/p47-Mediated biogenesis of Golgi and ER. J. Biochem. 137, 115-119
4. Wolf, D. H., and Stolz, A. (2011) The Cdc48 machine in endoplasmic reticulum associated protein degradation. Biochim. Biophys. Acta Jul 23. [Epub ahead of print].
5. Dargemont, C., and Ossareh-Nazari, B. (2011) Cdc48/p97, a key actor in the interplay between autophagy and ubiquitin/proteasome catabolic pathways. Biochim. Biophys. Acta Jul 23. [Epub ahead of print].
6. Yamanaka, K., Sasagawa, Y., and Ogura, T. (2011) Recent advances in p97/VCP/Cdc48 cellular functions. Biochim. Biophys. Acta Jul 12. [Epub ahead of print].
7. Meyer, H., and Popp, O. (2008) Role(s) of Cdc48/p97 in mitosis. Biochem. Soc. Trans. 36, 126-130
8. Ju, J. S., Fuentealba, R. A., Miller, S. E., Jackson, E., Piwnica-Worms, D., Baloh, R. H., and Weihl, C. C. (2009) Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 187, 875-888
9. Tresse, E., Salomons, F. A., Vesa, J., Bott, L. C., Kimonis, V., Yao, T. P., Dantuma, N. P., and Taylor, J. P. (2010) VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6, 217-227
10. Ritz, D., Vuk, M., Kirchner, P., Bug, M., Schütz, S., Hayer, A., Bremer, S., Lusk, C., Baloh, R. H., Lee, H., Glatter, T., Gstaiger, M., Aebersold, R., Weihl, C. C., and Meyer, H. (2011) Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations. Nat. Cell Biol. 13, 1116-1123
11. Ernst, R., Mueller, B., Ploegh, H. L., and Schlieker, C. (2009) The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER. Mol. Cell 36, 28-38
12. Koegl, M., Hoppe, T., Schlenker, S., Ulrich, H. D., Mayer, T. U., and Jentsch, S. (1999) A novel ubiquitination factor, E4, is involved in multiubiquitination chain assembly. Cell 96, 635-644
13. Rabinovich, E., Kerem, A., Fröhlich, K. U., Diamant, N., and Bar-Nun, S. (2002) AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 22, 626-634
14. Shcherbik, N., and Haines, D. S. (2007) Cdc48p(Np14p/Ufd1p) binds and segregates membrane-anchored/tethered complexes via a polyubiquitin signal present on the anchors. Mol. Cell 25, 385-397
15. Meyer, H. H., Wang, Y., and Warren, G. (2002) Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4. EMBO J. 21, 5645-5652
16. Madsen, L., Seeger, M., Semple, C. A., and Hartmann-Petersen, R. (2009) New ATPase regulators-p97 goes to the PUB. Int. J. Biochem. Cell Biol. 41, 2380-2388
17. Yeung, H. O., Kloppsteck, P., Niwa, H., Isaacson, R. L., Matthews, S., Zhang, X., and Freemont, P. S. (2008) Insights into adaptor binding to the AAA protein p97. Biochem. Soc. Trans. 36, 62-67
18. Schuberth, C., and Buchberger, A. (2008) UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97. Cell Mol. Life Sci. 65, 2360-2371
19. Alexandru, G., Graumann, J., Smith, G. T., Kolawa, N. J., Fang, R., and Deshaies, R. J. (2008) UBXD7 binds multiple ubiquitin ligases and implicates p97 in the H1F1alpha turnover. Cell 134, 804-816
20. Halawani, D., LeBlanc, A. C., Rouiller, I., Michnick, S. W., Servant, M. J., and Latterich, M. (2009) Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation. Mol. Cell. Biol. 29, 4484-4494
21. Fernández-Sáiz, V., and Buchberger, A. (2010) Imbalances in p97 co-factor interactions in human proteinopathy. EMBO Rep. 11, 479-485
22. Ramkumar, P., Smith, B. A., Akinbamidele, A. C., Kapcia, J., Beauparlant, S. L., and Haines, D. S. (2009) Generation and characterization of novel monoclonal antibodies recognizing UBXD1. Hybridoma 28, 459-462
23. Lee, J. E., Sweredoski, M. J., Graham, R., Ll Kolawa, N. J., Smith, G. T., Hess, S., and Deshaies, R. J. (2011) The steady-state repertoire of human SCF ubiquitin ligase complexes does not require ongoing Nedd8 conjugation. Mol. Cell. Proteomics 10, M110.006460
24. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide quantification. Nat. Biotechnol. 26, 1367-1372
25. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., and Mann, M. (2011) Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment. J. Proteome Res. 10, 1794-1805
26. Zhang, Y. C., Zhou, Y., Yang, C. Z., and Xiong, D. S. (2009) A review of ERGIC-53: its structure, functions, regulation and relations with diseases. Histol. Histopathol. 24, 1193-1204
27. Hauri, H. P., Kappeler, F., Anderson, H., and Appenzeller, C. (2000) ERGIC-53 and traffic in the secretory pathway. J. Cell Science 113, 587-596
28. Chou, T. F., Brown, S. J., Minond, D., Nordin, B. E., Li, K., Jones, A. C., Chase, P., Porubsky, P. R., Stoltz, B. M., Schoenen, F. J., Patricelli, M. P., Hodder, P., Rosen, H., and Deshaies, R. J. (2011) Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways. Proc. Natl. Acad. Sci. U.S.A. 108, 4834-4839
29. Yang, Y., Kitagaki, J., Dai, R. M., Tsai, Y. C., Lorick, K. L., Ludwig, R. L., Pierre, S. A., Jensen, J. P., Davydov, I. V., Oberoi, P., Li, C. C., Kenten, J. H., Beutler, J. A., Vousden, K. H., and Weissman, A. M. (2007) Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res. 67, 9472-9481
30. Scales, S. J., Pepperkok, R., and Kreis, T. E. (1997) Visualization of ER-to-Golgi transport in living cells reveals a sequential mode of action for COPII and COPI. Cell 90, 1137-1148
31. Müller, M., Pym, E. C., Tong, A., and Davis, G. W. (2011) Rab3-GAP controls the progression of synaptic homeostasis at a late stage of vesicle release. Neuron 69, 749-762
32. Kappeler, F., Itin, C., Schindler, R., and Hauri, H. P. (1994) A dual role for COOH-terminal lysine residues in pre-Golgi retention and endocytosis of ERGIC-53. J. Biol. Chem. 269, 6279-6281
33. Foster, L. J., de Hoog, C. L., Zhang, Y., Zhang, Y., Xie, X., Mootha, V. K., and Mann, M. (2006) A mammalian organelle map by protein correlation profiling. Cell 125, 187-199
34. Nyfeler, B., Reiterer, V., Wendeler, M. W., Stefan, E., Zhang, B., Michnick, S. W., and Hauri, H. P. (2008) Identification of ERGIC-53 as an intracellular transport receptor of alpha1-antitrypsin. J. Cell Biol. 180, 705-712
35. Nishio, M., Kamiya, Y., Mizushima, T., Wakatsuki, S., Sasakawa, H., Yamamoto, K., Uchiyama, S., Noda, M., McKay, A. R., Fukui, K., Hauri, H. P., and Kato, K. (2010) Structural basis for the cooperative interplay between the two causative gene products of combined V and factor VII deficiency. Proc. Natl. Acad. Sci. U.S.A. 107, 4034-4039
36. Vollenweider, F., Kappeler, F., Itin, C., and Hauri, H. P. (1998) Mistargeting of the lectin ERGIC-53 to the endoplasmic reticulum of HeLa cells impairs the secretion of a lysosomal enzyme. J. Cell Bio. 142, 377-389
37. Appenzeller, C., Andersson, H., Kappeler, F., and Hauri, H. P. (1999) The lectin ERGIC-53 is a cargo receptor for glycoproteins. Nat. Cell Biol. 1, 330-334
38. Spreafico, M., and Peyvandi, F. (2009) Combined Factor V and Factor VIII Deficiency. Semin. Thromb. Hemost. 35, 390-399
39. Zhang, B., Zheng, C., Zhu, M., Tao, J., Vasievich, M. P., Baines, A., Kim, J., Schekman, R., Kaufman, R. J., and Ginsburg, D. (2011) Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin. Blood 118, 3384-3391
40. Madsen, L., Andersen, K. M., Prag, S., Moos, T., Semple, C. A., Seeger, M., and Hartmann-Petersen, R. (2008) Ubxd1 is a novel co-factor of the human p97 ATPase. Int J Biochem. Int. J. Biochem. Cell Biol. 40, 2927-2942